Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Lung cancer is one of the most common cancers and the leading cause of deaths worldwide. The eighth volume of the “Interdisciplinary Cancer Research” series, entitled “Lung Cancer Pathophysiology: An Interdisciplinary Approach” publishes comprehensive reviews on the mechanisms of lung cancer. Fundamental elements of a lung cancer multidisciplinary team are discussed. The epithelial to mesenchymal transition in lung cancer, and the roles of tumor immune microenvironment, NK cells, RNA, micro-RNA, and long-non coding RNA in lung cancer are explained. A comprehensive genomic profiling in lung…mehr
Lung cancer is one of the most common cancers and the leading cause of deaths worldwide. The eighth volume of the “Interdisciplinary Cancer Research” series, entitled “Lung Cancer Pathophysiology: An Interdisciplinary Approach” publishes comprehensive reviews on the mechanisms of lung cancer. Fundamental elements of a lung cancer multidisciplinary team are discussed. The epithelial to mesenchymal transition in lung cancer, and the roles of tumor immune microenvironment, NK cells, RNA, micro-RNA, and long-non coding RNA in lung cancer are explained. A comprehensive genomic profiling in lung cancer in the era of immunotherapy approaches is also provided in this volume. This interdisciplinary series is of special value to researchers working on oncology. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value to researchers, oncologists, and oncosurgeons who wish to extend their knowledge on lung cancer.
Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital. Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research and Technologies, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the Founder of Universal Scientific Education and Research Network (USERN). Prof. Rezaei has already been the Director of more than two hundred research projects and has designed and participated in several international collaborative projects. Prof. Rezaei is the editor, editorial assistant, or editorial board member of more than fifty international journals. He has edited more than one hundred international books, has presented more than a thousand lectures/posters in congresses/meetings, and has published more than 1,500 scientific papers in the international journals.
Inhaltsangabe
Interdisciplinary Approach in Lung Cancers.- Fundamental Elements of a High-Functioning Lung Cancer Multidisciplinary Team (MDT).- Epithelial to Mesenchymal Transition in Lung Cancer: When It Starts?.- Roles of Tumor Immune Microenvironment in Non-small Cell Lung Cancer.- Natural Killer Cells in Lung Cancer.- RNA-binding Proteins as a New Link Between COPD and Lung Cancer.- The Implication of miRNA Signature in the Characteristic Features and Diagnosis of Lung Cancer.- MicroRNAs in the Immunopathology and Treatment of Non-small Cell Lung Cancer.- Monitoring Exosomal Non-coding RNA in Lung Cancers.- Mediastinal Staging of Lung Cancer.- Pleural Mesothelioma: The Importance of Working Together.- Comprehensive Genomic Profiling in Lung Cancer in the Era of Immunotherapy Approaches: The Role of Molecular Tumour Boards.
Interdisciplinary Approach in Lung Cancers.- Fundamental Elements of a High-Functioning Lung Cancer Multidisciplinary Team (MDT).- Epithelial to Mesenchymal Transition in Lung Cancer: When It Starts?.- Roles of Tumor Immune Microenvironment in Non-small Cell Lung Cancer.- Natural Killer Cells in Lung Cancer.- RNA-binding Proteins as a New Link Between COPD and Lung Cancer.- The Implication of miRNA Signature in the Characteristic Features and Diagnosis of Lung Cancer.- MicroRNAs in the Immunopathology and Treatment of Non-small Cell Lung Cancer.- Monitoring Exosomal Non-coding RNA in Lung Cancers.- Mediastinal Staging of Lung Cancer.- Pleural Mesothelioma: The Importance of Working Together.- Comprehensive Genomic Profiling in Lung Cancer in the Era of Immunotherapy Approaches: The Role of Molecular Tumour Boards.
Interdisciplinary Approach in Lung Cancers.- Fundamental Elements of a High-Functioning Lung Cancer Multidisciplinary Team (MDT).- Epithelial to Mesenchymal Transition in Lung Cancer: When It Starts?.- Roles of Tumor Immune Microenvironment in Non-small Cell Lung Cancer.- Natural Killer Cells in Lung Cancer.- RNA-binding Proteins as a New Link Between COPD and Lung Cancer.- The Implication of miRNA Signature in the Characteristic Features and Diagnosis of Lung Cancer.- MicroRNAs in the Immunopathology and Treatment of Non-small Cell Lung Cancer.- Monitoring Exosomal Non-coding RNA in Lung Cancers.- Mediastinal Staging of Lung Cancer.- Pleural Mesothelioma: The Importance of Working Together.- Comprehensive Genomic Profiling in Lung Cancer in the Era of Immunotherapy Approaches: The Role of Molecular Tumour Boards.
Interdisciplinary Approach in Lung Cancers.- Fundamental Elements of a High-Functioning Lung Cancer Multidisciplinary Team (MDT).- Epithelial to Mesenchymal Transition in Lung Cancer: When It Starts?.- Roles of Tumor Immune Microenvironment in Non-small Cell Lung Cancer.- Natural Killer Cells in Lung Cancer.- RNA-binding Proteins as a New Link Between COPD and Lung Cancer.- The Implication of miRNA Signature in the Characteristic Features and Diagnosis of Lung Cancer.- MicroRNAs in the Immunopathology and Treatment of Non-small Cell Lung Cancer.- Monitoring Exosomal Non-coding RNA in Lung Cancers.- Mediastinal Staging of Lung Cancer.- Pleural Mesothelioma: The Importance of Working Together.- Comprehensive Genomic Profiling in Lung Cancer in the Era of Immunotherapy Approaches: The Role of Molecular Tumour Boards.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG i.I. Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
